Skip to main content
. Author manuscript; available in PMC: 2013 Apr 25.
Published in final edited form as: N Engl J Med. 2012 Oct 25;367(17):1596–1606. doi: 10.1056/NEJMoa1207756

Table 3.

Colorectal Cancer–Specific Survival at 5 Years, According to Tumor PIK3CA Mutation Status and Use or Nonuse of Aspirin after Diagnosis.*

PIK3CA No. of Patients Dead at 5 Yr after Diagnosis Alive at 5 Yr after Diagnosis P Value
number (percent)
Wild-type 0.92
    No aspirin use 440 65 (15) 375 (85)
    Aspirin use 319 48 (15) 271 (85)
Mutant <0.001
    No aspirin use 90 23 (26) 67 (74)
    Aspirin use 62 2 (3) 60 (97)
*

P values were calculated with the use of Fisher's exact test.